A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer: North Japan Lung Cancer Study Group 2202

The present multicenter study was performed to compare the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy with that of combined EGFR-TKI plus vascular endothelial growth factor receptor (VEGF) inhibitor/cytotoxic therapy in patients with programmed deat...

Descripción completa

Detalles Bibliográficos
Autores principales: Inomata, Minehiko, Kawashima, Yosuke, Saito, Ryota, Morinaga, Daisuke, Nogawa, Hitomi, Sato, Masamichi, Suzuki, Yohei, Yanagisawa, Satoru, Kikuchi, Takashi, Jingu, Daisuke, Yoshimura, Naruo, Harada, Toshiyuki, Miyauchi, Eisaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326654/
https://www.ncbi.nlm.nih.gov/pubmed/37427337
http://dx.doi.org/10.3892/ol.2023.13920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326654/
https://www.ncbi.nlm.nih.gov/pubmed/37427337
http://dx.doi.org/10.3892/ol.2023.13920

Ejemplares similares